111 related articles for article (PubMed ID: 35797753)
21. Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.
Goense L; Visser E; Haj Mohammad N; Mook S; Verhoeven RHA; Meijer GJ; van Rossum PSN; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2018 May; 44(5):620-625. PubMed ID: 29478739
[TBL] [Abstract][Full Text] [Related]
22. External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer.
Brinkmann S; Noordman BJ; Hölscher AH; Biermann K; van Klaveren D; Bollschweiler E; Pütz K; van Lanschot JJB; Drebber U
Ann Surg Oncol; 2020 Apr; 27(4):1250-1258. PubMed ID: 31691114
[TBL] [Abstract][Full Text] [Related]
23. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
24. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.
Chopra A; Zenati M; Hogg ME; Zeh HJ; Bartlett DL; Bahary N; Zureikat AH; Beane JD
Ann Surg Oncol; 2021 Nov; 28(12):7759-7769. PubMed ID: 34027585
[TBL] [Abstract][Full Text] [Related]
25. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.
Hölscher AH; Drebber U; Schmidt H; Bollschweiler E
Ann Surg; 2014 Nov; 260(5):779-84; discussion 784-5. PubMed ID: 25379849
[TBL] [Abstract][Full Text] [Related]
26. Importance of Lymph Node Response After Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
Depypere L; De Hertogh G; Moons J; Provoost AL; Lerut T; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Ann Thorac Surg; 2021 Dec; 112(6):1847-1854. PubMed ID: 33352178
[TBL] [Abstract][Full Text] [Related]
27. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
[TBL] [Abstract][Full Text] [Related]
28. Signet Ring Cell Features are Associated with Poor Response to Neoadjuvant Treatment and Dismal Survival in Patients with High-Grade Esophageal Adenocarcinoma.
Solomon D; Abbas M; Feferman Y; Haddad R; Perl G; Kundel Y; Morgenstern S; Menasherov N; Kashtan H
Ann Surg Oncol; 2021 Sep; 28(9):4929-4940. PubMed ID: 33709175
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
Adam MA; Glencer A; AlMasri S; Winters S; Bahary N; Singhi A; Lee KK; Paniccia A; Zureikat AH
Ann Surg Oncol; 2023 Jan; 30(1):165-174. PubMed ID: 35925536
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
Nassour I; Adam MA; Kowalsky S; Al Masri S; Bahary N; Singhi AD; Lee K; Zureikat A; Paniccia A
J Surg Oncol; 2021 Jan; 123(1):245-251. PubMed ID: 33103242
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
[TBL] [Abstract][Full Text] [Related]
32. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
Becerra AZ; Wexner SD; Dietz DW; Xu Z; Aquina CT; Justiniano CF; Swanger AA; Temple LK; Noyes K; Monson JR; Fleming FJ
Ann Surg Oncol; 2018 Aug; 25(8):2332-2339. PubMed ID: 29850952
[TBL] [Abstract][Full Text] [Related]
33. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
34. Survival impact of neoadjuvant therapy in resected pancreatic cancer: A Prospective Cohort Study involving 18,332 patients from the National Cancer Data Base.
Mirkin KA; Hollenbeak CS; Wong J
Int J Surg; 2016 Oct; 34():96-102. PubMed ID: 27573691
[TBL] [Abstract][Full Text] [Related]
35. Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.
Raman V; Jawitz OK; Voigt SL; Rhodin KE; Kim AW; Tong BC; D'Amico TA; Harpole DH
Ann Thorac Surg; 2020 Dec; 110(6):1832-1839. PubMed ID: 32622794
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer.
Kamarajah SK; Newton N; Navidi M; Wahed S; Immanuel A; Hayes N; Griffin SM; Phillips AW
Dis Esophagus; 2020 Aug; 33(8):. PubMed ID: 31950184
[TBL] [Abstract][Full Text] [Related]
37. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
[TBL] [Abstract][Full Text] [Related]
38. Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer.
Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
Int J Surg; 2018 Apr; 52():221-228. PubMed ID: 29425826
[TBL] [Abstract][Full Text] [Related]
39. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients.
Wu L; Xing Z; Huang M; Yu H; Qin Y; Jin Q; Zhou Z; Chen J
J Surg Oncol; 2022 Dec; 126(8):1403-1412. PubMed ID: 36001384
[TBL] [Abstract][Full Text] [Related]
40. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]